| Medication | Concern | |------------|---------| | | May reduce uterine blood flow; avoid in 1st trimester and if you have hypertension. Do not use with preeclampsia. | | Phenylephrine | Even less evidence than pseudoephedrine; generally avoided. | | Intranasal decongestant sprays (oxymetazoline – Afrin) | Short-term use only (max 3 days) to avoid rebound congestion. Limited safety data, but risk appears low. |
| Medication | Concern | |------------|---------| | | May reduce uterine blood flow; avoid in 1st trimester and if you have hypertension. Do not use with preeclampsia. | | Phenylephrine | Even less evidence than pseudoephedrine; generally avoided. | | Intranasal decongestant sprays (oxymetazoline – Afrin) | Short-term use only (max 3 days) to avoid rebound congestion. Limited safety data, but risk appears low. |